THOMAS CHRISTENSEN NEW CFO FOR SCN

(NGM: SCN)

SCN continues to reinforce the company’s management by appointing Thomas Christensen as new CFO. Christensen has extensive experience from performance measurement, corporate finance, IR, PR, finance and restructuring, and took his position on January 1, 2008.

“One of the foremost strengths of SCN is our management team. With Thomas Christensen as CFO, the company gains additional international experience in the fields of finance, organization, IR and PR. Recruiting Christensen also gives us a stronger presence and network on the Norwegian market, where we have our primary listing”, says Ulf Söderberg, CEO of SCN.

Thomas Christensen is a Norwegian citizen with extensive international leadership experience. His most recent positions were in the Norwegian companies NetConnect Systems AS (CFO) and Active 24 ASA (CEO and CFO). Christensen also has several years of experience from different CFO positions in USA, and holds a Bachelor of Science and an MBA from the Norwegian School of Management (BI).

SCN is also planning on reinforcing the Board of Directors with an additional independent Board Member. On the next General Meeting, the Norwegian lawyer and investor Ola Røthe will be suggested for election by some of the company’s major shareholders. Røthe was the first Managing Director of Norwegian Natural ASA, and has served on the Board of Swedish Bringwell AB, thus gaining experience of working actively within SCN’s field of business.

For further information, please contact:

Ulf Söderberg, CEO, us@scnutrition.com, +46 708 13 22 81

Thomas Christensen, CFO, tc@scnutrition.com, +47 922 55 444

Scandinavian Clinical Nutrition AB (publ) works in R&D and sales of scientifically documented products within the field of nutrition (nutraceuticals). Established in 2006, SCN maintains a product portfolio with established trademarks such as CUUR, Coldizin, Immulina, Ledactin and Membraseven. Core competence and strategic alliances within both R&D and sales, in combination with innovative and scientifically documented products, create the right conditions for profitable growth both in Sweden and on the company’s export markets. The SCN shares are traded under the ticker “SCN” on Oslo Axess (www.osloaxess.no) and NGM Equity (www.ngm.se).